125-33-7
125-33-7
Chemical Structure
Primidone
- CAS No.: 125-33-7
- Formula:C12H14N2O2
- Molecular Weight:218.25
IUPAC Name: 5-ethyl-5-phenyldihydropyrimidine-4,6(1H,5H)-dione
InChIKey: DQMZLTXERSFNPB-UHFFFAOYSA-N
SMILES: O=C(C1(CC)C2=CC=CC=C2)NCNC1=O
Biological Activity: Primidone is the orally active inhibitor for TRPM3 (IC50 = 0.6 μM), RIP kinase and voltage-gated sodium channel, and the antagonist for GABA receptor. Primidone can be used as the analgesic and anticonvulsant agent[1][2][3].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Primidone | 99.96% | Primidone is the orally active inhibitor for TRPM3 (IC50 = 0.6 μM), RIP kinase and voltage-gated sodium channel, and the antagonist for GABA receptor. Primidone can be used as the analgesic and anticonvulsant agent. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Primidone (Standard) | 99.97% | Primidone (Standard) is the analytical standard of Primidone. This product is intended for research and analytical applications. Primidone is the orally active inhibitor for TRPM3 (IC50 = 0.6 μM), RIP kinase and voltage-gated sodium channel, and the antagonist for GABA receptor. Primidone can be used as the analgesic and anticonvulsant agent. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Primidone-d5 | 99.00% | Primidone-d5 is the deuterium labeled Primidone. Primidone is the orally active inhibitor for TRPM3 (IC50 = 0.6 μM), RIP kinase and voltage-gated sodium channel, and the antagonist for GABA receptor. Primidone can be used as the analgesic and anticonvulsant agent. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Krügel U, et al., Primidone inhibits TRPM3 and attenuates thermal nociception in vivo. Pain. 2017 May;158(5):856-867. [Content Brief]
- [2]. Riebeling T, et al., Primidone blocks RIPK1-driven cell death and inflammation. Cell Death Differ. 2021 May;28(5):1610-1626. [Content Brief]
- [3]. Vogelnik Žakelj K, et al., Mechanisms of tremor-modulating effects of primidone and propranolol in essential tremor. Parkinsonism Relat Disord. 2024 Nov;128:107151. [Content Brief]
